India may soon have a third Covid-19 vaccine in the next few weeks with emergency use authorisation for the Russian jab Sputnik V.
“We expect to get the approval in the next few weeks,” said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL).
DRL had applied for restricted emergency use authorisation for Sputnik V in February. It has already lined up over 250 million doses of the vaccine for Indian citizens (from manufacturing partners) over the next 12 months.
The Russian Direct Investment Fund (RDIF) has formed manufacturing tie-ups with several partners in India to make around 752 million doses

)